1. Home
  2. Live Updates
  3. அம்புக்குறி மருந்துகள் அறிக்கைகள் நிதி

அம்புக்குறி மருந்துகள் அறிக்கைகள் நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அம்புக்குறி மருந்துகள் அறிக்கைகள் நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அம்புக்குறி மருந்துகள் அறிக்கைகள் நிதி Today - Breaking & Trending Today

Nanotechnology Now - Press Release: 180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor


Nanotechnology Now
Our NanoNews Digest Sponsors
Home > Press > 180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor
Abstract:
180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported its financial results as of December 31, 2020, and additional developments from the first quarter of 2021. The Company also published a letter to shareholders that can be viewed at https://ir.180degreecapital.com/financial-results .
180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor ....

Nordrhein Westfalen , Kevinm Rendino , Daniel Wolfe , Danielb Wolfe , Evaluation Committee , Arrowhead Pharmaceuticals To Webcast Fiscal , Arrowhead Pharmaceuticals Reports Fiscal , Securities Of Publicly Traded Companies , Shareholders Of Enzo Biochem Inc , Exchange Commission , University Of Bonn , Degree Capital Corp , Wave Inc , Asset Value , Expected Investment , Chief Executive Officer , Portfolio Gross Total Return , Stock Price , Publicly Traded Companies , Micro Cap Index , Microcap Value Index , Chief Financial Officer , Portfolio Manager , Eastern Time , Nanotechnology Now , Report Fourth Quarter ,

Nanotechnology Now - Press Release: 180 Degree Capital Corp. to Report Fourth Quarter 2020 Financial Results on Monday, February 22, 2021 and to Host a Conference Call on Tuesday, February 23, 2021


Nanotechnology Now
Our NanoNews Digest Sponsors
Home > Press > 180 Degree Capital Corp. to Report Fourth Quarter 2020 Financial Results on Monday, February 22, 2021 and to Host a Conference Call on Tuesday, February 23, 2021
Abstract:
180 Degree Capital Corp. (NASDAQ: TURN) will announce its fourth quarter 2020 financial results on Monday, February 22, 2021, shortly after the close of the public markets. It will host a conference call on Tuesday, February 23, 2021, at 9am Eastern Time to discuss these results and updates from Q1 2021.
180 Degree Capital Corp. to Report Fourth Quarter 2020 Financial Results on Monday, February 22, 2021 and to Host a Conference Call on Tuesday, February 23, 2021
Montclair, NJ | Posted on February 19th, 2021 ....

Danielb Wolfe , Smart Technology , Oxford Instruments Plasma Technology , Arrowhead Pharmaceuticals To Webcast Fiscal , Arrowhead Pharmaceuticals Reports Fiscal , Million Stock Buyback Program , Shareholders Of Enzo Biochem Inc , Exchange Commission , International Dial , Degree Capital Corp , Wave Inc , Arrowhead Pharmaceuticals To Participate In Upcoming Conferences , Report Fourth Quarter , Conference Call , Eastern Time , Dial In Number , Dial In Numbers , Nanotechnology Now , Flexible Terahertz Camera Can Inspect Objects , Diverse Shapes February , Instruments Plasma Technology , Issues Open Letter , Enzo Biochem , Stock Split January , Stock Buyback Program , Stock Split ,